tirzepatide dangerous side effects and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Semaglutide and Tirzepatide Side Effects

One serious issue people with diabetes might deal with is diabetic ulcers

Potential Cardiovascular Benefits : Some GLP-1 agonists, such as semaglutide, have shown to reduce the risk of major cardiovascular events (e.g., heart attacks, strokes), particularly in patients with type 2 diabetes

The evidence reviewed clearly supports that treating these conditions isolated is less effective than a holistic approach that addresses both metabolic and mental health aspects

Together, these data demonstrated that 10 nM tirzepatide effectively reverses HFD-induced obesity and metabolic imbalance, improves both energy expenditure and insulin sensitivity

10.1371/journal.pone.0192441 224

Efficacy and Safety of Setmelanotide, an mc4r Agonist, in Individuals With Severe Obesity Due to Lepr or Pomc Deficiency: Single-Arm, Open-Label, Multicentre, Phase 3 Trials